ATE86867T1 - Thrombolytische zusammensetzung enthaltender gewebetyp, plasminogenaktivatoren oder derivate davon. - Google Patents
Thrombolytische zusammensetzung enthaltender gewebetyp, plasminogenaktivatoren oder derivate davon.Info
- Publication number
- ATE86867T1 ATE86867T1 AT90310288T AT90310288T ATE86867T1 AT E86867 T1 ATE86867 T1 AT E86867T1 AT 90310288 T AT90310288 T AT 90310288T AT 90310288 T AT90310288 T AT 90310288T AT E86867 T1 ATE86867 T1 AT E86867T1
- Authority
- AT
- Austria
- Prior art keywords
- salt
- tissue type
- derivatives
- type containing
- plasminogen activators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Preliminary Treatment Of Fibers (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24331089 | 1989-09-21 | ||
EP90310288A EP0419252B1 (de) | 1989-09-21 | 1990-09-20 | Thrombolytische Zusammensetzung enthaltender Gewebetyp, Plasminogenaktivatoren oder Derivate davon |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE86867T1 true ATE86867T1 (de) | 1993-04-15 |
Family
ID=17101932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90310288T ATE86867T1 (de) | 1989-09-21 | 1990-09-20 | Thrombolytische zusammensetzung enthaltender gewebetyp, plasminogenaktivatoren oder derivate davon. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6051223A (de) |
EP (1) | EP0419252B1 (de) |
JP (1) | JP2520975B2 (de) |
KR (1) | KR930008908B1 (de) |
CN (1) | CN1041799C (de) |
AT (1) | ATE86867T1 (de) |
BR (1) | BR9004692A (de) |
CA (1) | CA2025317C (de) |
DE (1) | DE69001110T2 (de) |
DK (1) | DK0419252T3 (de) |
ES (1) | ES2054263T3 (de) |
FI (1) | FI104953B (de) |
GR (1) | GR3007396T3 (de) |
NO (1) | NO904119L (de) |
NZ (1) | NZ235298A (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207151B1 (en) * | 1989-09-21 | 2001-03-27 | Mitsui Chemicals Inc. | Aqueous solution of t-PA |
US5272076A (en) * | 1991-06-13 | 1993-12-21 | Eli Lilly And Company | Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA |
US6527979B2 (en) * | 1999-08-27 | 2003-03-04 | Corazon Technologies, Inc. | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
JP4395540B2 (ja) * | 2006-03-27 | 2010-01-13 | 農工大ティー・エル・オー株式会社 | トリプレニルフェノール化合物及びトリプレニルフェノール化合物の製造方法並びに、血栓溶解促進剤 |
CA2876177C (en) | 2012-06-11 | 2022-06-14 | The Cleveland Clinic Foundation | Treatment and prevention of cardiovascular disease and thrombosis |
CN103191054B (zh) * | 2013-04-19 | 2015-05-27 | 范克 | 一种肝素钠封管注射液及其制备方法 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2310133A2 (fr) * | 1975-05-05 | 1976-12-03 | Fabre Sa Pierre | Nouveau medicament comportant un activateur du plasminogene perfectionne |
JPS52145591A (en) * | 1976-05-28 | 1977-12-03 | Kanebo Ltd | Stabilization of urokinase |
JPS5467089A (en) * | 1977-11-07 | 1979-05-30 | Dainippon Pharmaceut Co Ltd | Urokinase composition |
JPS5568290A (en) * | 1978-11-16 | 1980-05-22 | Kanebo Ltd | Stabilization of urokinase |
JPS59196824A (ja) * | 1983-04-21 | 1984-11-08 | Kowa Co | 吸着防止剤 |
JPS60158116A (ja) * | 1984-01-30 | 1985-08-19 | Asahi Chem Ind Co Ltd | 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤 |
JPS60158117A (ja) * | 1984-01-30 | 1985-08-19 | Asahi Chem Ind Co Ltd | 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤 |
JPS60184026A (ja) * | 1984-03-01 | 1985-09-19 | Asahi Chem Ind Co Ltd | 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法 |
JPS60181028A (ja) * | 1984-02-29 | 1985-09-14 | Asahi Chem Ind Co Ltd | 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法 |
WO1986005095A1 (en) * | 1985-03-06 | 1986-09-12 | Survival Technology, Inc. | t-PA COMPOSITION AND METHOD OF GETTING INTO BLOOD STREAM |
DE3512910A1 (de) * | 1985-04-11 | 1986-10-16 | Behringwerke Ag, 3550 Marburg | Verfahren zur reinigung von plasminogenaktivatoren |
DE3512909A1 (de) * | 1985-04-11 | 1986-10-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung von plasminogenaktivatoren (pa) |
DE3512908A1 (de) * | 1985-04-11 | 1986-10-23 | Behringwerke Ag, 3550 Marburg | Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel |
JPH0669960B2 (ja) * | 1985-11-22 | 1994-09-07 | エーザイ株式会社 | 水溶性を増加したtPA含有医薬組成物 |
ATE83153T1 (de) * | 1985-09-10 | 1992-12-15 | Eisai Co Ltd | Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung. |
JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
JPS62120321A (ja) * | 1985-11-20 | 1987-06-01 | Eisai Co Ltd | tPA含有医薬組成物 |
US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
JPH0678241B2 (ja) * | 1986-04-02 | 1994-10-05 | エーザイ株式会社 | tPA医薬組成物 |
JPS62292729A (ja) * | 1986-06-12 | 1987-12-19 | Toyobo Co Ltd | ヒト子宮組織由来プラスミノ−ゲン活性化因子製剤 |
US4857320A (en) * | 1987-02-19 | 1989-08-15 | Monsanto Company | Method of enhancing the solubility of tissue plasminogen activator |
DE3718889A1 (de) * | 1987-06-05 | 1988-12-22 | Behringwerke Ag | Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin |
JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
JPH06226234A (ja) * | 1993-02-01 | 1994-08-16 | Shojiro Takeuchi | 産業廃棄物の炭化処理方法 |
JPH06236332A (ja) * | 1993-02-09 | 1994-08-23 | Oki Electric Ind Co Ltd | プログラムローディング装置 |
JPH06259221A (ja) * | 1993-03-05 | 1994-09-16 | Tokyo Electric Co Ltd | 画面表示器を備えた情報処理装置 |
JPH06281326A (ja) * | 1993-03-30 | 1994-10-07 | Shibaura Eng Works Co Ltd | 洗浄物の乾燥方法 |
-
1990
- 1990-08-31 JP JP2227936A patent/JP2520975B2/ja not_active Expired - Lifetime
- 1990-09-13 NZ NZ235298A patent/NZ235298A/xx unknown
- 1990-09-13 CA CA002025317A patent/CA2025317C/en not_active Expired - Fee Related
- 1990-09-19 FI FI904617A patent/FI104953B/fi not_active IP Right Cessation
- 1990-09-20 DK DK90310288.7T patent/DK0419252T3/da active
- 1990-09-20 BR BR909004692A patent/BR9004692A/pt not_active Application Discontinuation
- 1990-09-20 ES ES90310288T patent/ES2054263T3/es not_active Expired - Lifetime
- 1990-09-20 EP EP90310288A patent/EP0419252B1/de not_active Expired - Lifetime
- 1990-09-20 DE DE9090310288T patent/DE69001110T2/de not_active Expired - Fee Related
- 1990-09-20 NO NO90904119A patent/NO904119L/no unknown
- 1990-09-20 AT AT90310288T patent/ATE86867T1/de not_active IP Right Cessation
- 1990-09-21 CN CN90107989A patent/CN1041799C/zh not_active Expired - Fee Related
- 1990-09-21 KR KR1019900015031A patent/KR930008908B1/ko not_active IP Right Cessation
-
1993
- 1993-02-22 US US08/021,652 patent/US6051223A/en not_active Expired - Fee Related
- 1993-03-18 GR GR920403219T patent/GR3007396T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2520975B2 (ja) | 1996-07-31 |
DK0419252T3 (da) | 1993-04-19 |
FI104953B (fi) | 2000-05-15 |
EP0419252A1 (de) | 1991-03-27 |
CA2025317A1 (en) | 1991-03-22 |
AU619697B2 (en) | 1992-01-30 |
NO904119L (no) | 1991-03-22 |
NO904119D0 (no) | 1990-09-20 |
BR9004692A (pt) | 1991-09-10 |
ES2054263T3 (es) | 1994-08-01 |
KR930008908B1 (ko) | 1993-09-17 |
GR3007396T3 (de) | 1993-07-30 |
JPH0418032A (ja) | 1992-01-22 |
FI904617A0 (fi) | 1990-09-19 |
CA2025317C (en) | 1996-05-07 |
AU6246790A (en) | 1991-03-28 |
CN1050321A (zh) | 1991-04-03 |
NZ235298A (en) | 1992-12-23 |
KR910005883A (ko) | 1991-04-27 |
CN1041799C (zh) | 1999-01-27 |
DE69001110T2 (de) | 1993-06-24 |
EP0419252B1 (de) | 1993-03-17 |
DE69001110D1 (de) | 1993-04-22 |
US6051223A (en) | 2000-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60036017T2 (de) | Verfahren zur thrombolyse durch lokale behandlung mit reversibel inaktiviertem, angesäuertem plasmin | |
FI875533A0 (fi) | Insulinpreparat foer non-parenteral dosering. | |
NO871199D0 (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater med langvarige frigjoeringsegenskaper. | |
FI882605A0 (fi) | Menetelmä, jonka avulla voidaan valmistaa suuren spesifisen tilavuusaktiivisuuden omaavaa liuosta proteiinista, jolla on kudosplasminogeeniaktivaattori(t-PA)-aktiivisuutta | |
DE3680271D1 (de) | Thrombolytische zusammensetzung und verfahren zu deren herstellung. | |
KR880013572A (ko) | 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도 | |
ATE86867T1 (de) | Thrombolytische zusammensetzung enthaltender gewebetyp, plasminogenaktivatoren oder derivate davon. | |
CH637992A5 (de) | Verfahren zur herstellung eines komplexes aus streptokinase und einer leichten (b) plasmin-kettenfraktion mit einem aktiven serinprotease-zentrum. | |
ATE82132T1 (de) | Auf ligninsulfonat aufgebautes pharmazeutisches mittel mit einer atithrombose-aktivitaet. | |
PT89802A (pt) | Processo para a preparacao de uma composicao farmaceutica, contendo o factor xiii de coagulacao do sangue humano, para a prevencao da hemorragia intraventricular em criancas permaturas | |
FI91710B (fi) | Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi | |
FI98891B (fi) | Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi | |
Aoki et al. | Potentiation by synthetic fibrinolytic agents of vascular activator-and urokinase-induced lysis of human plasma clots as demonstrated by thrombelastography | |
DE68905577D1 (de) | Doxorubicin-loesungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |